FDA Enforcement Heating Up

Law360, New York (November 20, 2009, 12:48 PM ET) -- Recent statements by U.S. Food and Drug Administration and Department of Justice officials, including FDA Commissioner Margaret Hamburg, promised an increase in enforcement. Recent events on several fronts demonstrate that this is no idle threat.

On Oct. 28, 2009, the government announced a criminal indictment against Stryker Biotech and four current or past executives.

The indictment, filed in federal court in Massachusetts, alleges that the company and the named executives promoted an unapproved combination of two orthopedic products used as bone fillers.

Each product had been...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles